Neoplasms
|
0.060 |
AlteredExpression
|
group |
BEFREE |
The relative expression and transcript size of ER mRNA and TRPM-2 mRNA in 126 primary breast tumors were measured by Northern analysis and compared with tumor grade, hormone receptor status, extent of tumor necrosis, and survival.
|
8252481 |
1993 |
Malignant neoplasm of breast
|
0.020 |
Biomarker
|
disease |
BEFREE |
Relationship between variant forms of estrogen receptor RNA and an apoptosis-related RNA, TRPM-2, with survival in patients with breast cancer.
|
8252481 |
1993 |
Breast Carcinoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
Relationship between variant forms of estrogen receptor RNA and an apoptosis-related RNA, TRPM-2, with survival in patients with breast cancer.
|
8252481 |
1993 |
Mammary Neoplasms
|
0.010 |
AlteredExpression
|
group |
BEFREE |
The presence of smaller variant forms of ER mRNA either alone or in association with the normal ER transcript is not indicative of an unfavorable prognosis, whereas TRPM-2 mRNA occurs in many primary breast tumors, but has no apparent relationship to survival.
|
8252481 |
1993 |
Tumor Progression
|
0.020 |
AlteredExpression
|
phenotype |
BEFREE |
The uncoupling of TRPM-2 expression and apoptosis observed in androgen-independent tumour cells implies that the function of androgen receptor becomes more restricted with tumour progression.
|
8049130 |
1994 |
Carcinoma
|
0.010 |
Biomarker
|
group |
BEFREE |
Expression of the ADS31/YPT1, ADS39 and TRPM-2 genes was sensitive to androgen withdrawal and replacement both in the parent androgen-dependent and the recurrent androgen-independent carcinomas.
|
8049130 |
1994 |
Prostatic Neoplasms
|
0.010 |
AlteredExpression
|
group |
BEFREE |
Xenografts derived from a human prostate tumor cell line (PC-3) regressed following treatment with MDL 101,731 and the relative levels of TRPM-2 mRNA increased up to threefold in drug-treated animals.
|
8549673 |
1996 |
Bipolar Disorder
|
0.370 |
GeneticVariation
|
disease |
LHGDN |
These findings suggest genetic variants of the TRPM2 gene increase risk for BD and support the notion that TRPM2 may be involved in the pathophysiology of BD.
|
16252251 |
2006 |
Bipolar Disorder
|
0.370 |
GeneticVariation
|
disease |
BEFREE |
The aim of this study was an identification of mutations in the coding sequences of ADARB1 and TRPM2 and their association with bipolar affective disorder.
|
16733555 |
2006 |
Bipolar Disorder
|
0.370 |
Biomarker
|
disease |
BEFREE |
These findings suggest genetic variants of the TRPM2 gene increase risk for BD and support the notion that TRPM2 may be involved in the pathophysiology of BD.
|
16252251 |
2006 |
Transient Ischemic Attack
|
0.200 |
Biomarker
|
disease |
RGD |
TRPM2 is elevated in the tMCAO stroke model, transcriptionally regulated, and functionally expressed in C13 microglia.
|
16777714 |
2006 |
Epilepsy
|
0.020 |
Biomarker
|
disease |
BEFREE |
TRPM2 encodes a calcium channel receptor and TSPEAR encodes a peptide with repeats associated with epilepsy in the mouse.
|
16205735 |
2006 |
Mood Disorders
|
0.010 |
GeneticVariation
|
group |
LHGDN |
Screening of chromosomal region 21q22.3 for mutations in genes associated with neuronal Ca2+ signalling in bipolar affective disorder.
|
16733555 |
2006 |
Bipolar I disorder
|
0.010 |
Biomarker
|
disease |
BEFREE |
Reduced mRNA levels of the transient receptor potential Ca(2+) permeable channel melastatin type 2, TRPM2, in B lymphoblast cell lines (BLCL) from bipolar I disorder (BD-I) patients showing elevated basal intracellular Ca(2+) ([Ca(2+)](B)), an index of altered intracellular Ca(2+) homeostasis, along with its location within a putative BD susceptibility locus (21q22.3), implicates the involvement of this gene in the Ca(2+) abnormalities and the genetic diathesis to BD.
|
16252251 |
2006 |
MAJOR AFFECTIVE DISORDER 2
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The aim of this study was an identification of mutations in the coding sequences of ADARB1 and TRPM2 and their association with bipolar affective disorder.
|
16733555 |
2006 |
MAJOR AFFECTIVE DISORDER 1
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The aim of this study was an identification of mutations in the coding sequences of ADARB1 and TRPM2 and their association with bipolar affective disorder.
|
16733555 |
2006 |
MAJOR AFFECTIVE DISORDER 4
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The aim of this study was an identification of mutations in the coding sequences of ADARB1 and TRPM2 and their association with bipolar affective disorder.
|
16733555 |
2006 |
MAJOR AFFECTIVE DISORDER 6
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The aim of this study was an identification of mutations in the coding sequences of ADARB1 and TRPM2 and their association with bipolar affective disorder.
|
16733555 |
2006 |
MAJOR AFFECTIVE DISORDER 7
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The aim of this study was an identification of mutations in the coding sequences of ADARB1 and TRPM2 and their association with bipolar affective disorder.
|
16733555 |
2006 |
MAJOR AFFECTIVE DISORDER 8
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The aim of this study was an identification of mutations in the coding sequences of ADARB1 and TRPM2 and their association with bipolar affective disorder.
|
16733555 |
2006 |
MAJOR AFFECTIVE DISORDER 9
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The aim of this study was an identification of mutations in the coding sequences of ADARB1 and TRPM2 and their association with bipolar affective disorder.
|
16733555 |
2006 |
Neurodegenerative Disorders
|
0.060 |
Biomarker
|
group |
BEFREE |
Recent findings implicating TRPM7 and TRPM2 in oxidative stress-induced neuronal death thrust these channels into the spotlight as possible therapeutic targets for neurodegenerative diseases.
|
17395433 |
2007 |
Amyotrophic Lateral Sclerosis
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
TRPM7 and TRPM2-Candidate susceptibility genes for Western Pacific ALS and PD?
|
17395433 |
2007 |
Malignant Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
TRPM2 seems to be a candidate for gene therapy in glioblastoma cells, since the insertion of TRPM2 into A172 cells can facilitate cell death through Ca2+ increase after H2O2 treatment without increasing malignancy.
|
18225560 |
2008 |
Malignant Neoplasms
|
0.100 |
GeneticVariation
|
group |
BEFREE |
Identification of novel sense and antisense transcription at the TRPM2 locus in cancer.
|
18957938 |
2008 |